Cardiorespiratory Fitness Tied to Reduced Cancer Incidence, Mortality in Men
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, July 3, 2023 -- Higher levels of cardiorespiratory fitness (CRF) are associated with a reduced risk for incidence and mortality from specific cancers among men, according to a study published online June 29 in JAMA Network Open.
Elin Ekblom-Bak, Ph.D., from The Swedish School of Sport and Health Sciences in Stockholm, and colleagues conducted a prospective cohort study in a population of men who completed a health profile assessment between October 1982 and December 2019 in Sweden to examine the association between CRF and prostate, colon, and lung cancer incidence and mortality. Data were analyzed for 177,709 men.
The researchers found that higher levels of CRF were associated with a significantly lower risk for colon and lung cancer incidence (hazard ratio, 0.98 for both) and with an increased risk for prostate cancer incidence (hazard ratio, 1.01). A lower risk for death due to colon, lung, and prostate cancer was seen in association with higher CRF (hazard ratios, 0.98, 0.97, and 0.95, respectively). For colon cancer incidence, the associations remained for moderate and high levels compared with very low levels of CRF (hazard ratios, 0.72 and 0.63, respectively) in fully adjusted models. For prostate cancer mortality, the associations remained for low, moderate, and high CRF (hazard ratios, 0.67, 0.57, and 0.29, respectively). Only high CRF was significant for lung cancer mortality (hazard ratio, 0.41).
"If these findings can be supported with randomized clinical trials, CRF appears to have a potentially important role in reducing the risk of developing and dying from certain common cancers in men," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Higher County-Level Prostate Cancer Screening Tied to Better Outcomes
FRIDAY, June 7, 2024 -- Higher county-level prevalence of prostate-specific antigen (PSA) screening is associated with lower odds of advanced disease, all-cause mortality, and...
ASCO: Germline Variation Does Not Predict Taxane-Induced Peripheral Neuropathy
FRIDAY, June 7, 2024 -- Germline variation does not predict the risk of taxane-induced peripheral neuropathy (TIPN) in Black women receiving paclitaxel (once weekly) or docetaxel...
Prevalence of Cardiovascular Risk Factors, Diseases Set to Increase
THURSDAY, June 6, 2024 -- The prevalence of cardiovascular risk factors and diseases will increase through 2050, and the associated economic burden is also projected to increase...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.